DS
Insider selling
Da Silva Jorge Santos sold $2M of MoonLake Immunotherapeutics (MLTX) stock
Da Silva Jorge Santos, Chief Executive Officer of MoonLake Immunotherapeutics (MLTX), sold 102,225 shares of MLTX stock worth $2M, per an SEC Form 4 filed Jul 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 9, 2026, 4 days before it was made public.
MLTX has moved -37.0% since the trade date, from $19.93 to $12.55 (Sep 21, 2026 close).
- Traded
- Jul 9, 2026
- Disclosed
- Jul 13, 2026
- Filing delay
- 4 days
- Price since
- -37.0%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More MLTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.